Regulus Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Regulus Therapeutics Inc.

Regulus Therapeutics Inc. | Key People and Executives

Joseph P. Hagan

President, Chief Executive Officer & Director

Stelios B. Papadopoulos

Chairman

Kathryn J. Collier

Independent Director

Pascale Witz

Independent Director

Hugh Rosen

Independent Director

David Baltimore

Independent Director

William H. Rastetter

Independent Director

Joseph P. Hagan

President, Chief Executive Officer & Director

Daniel R. Chevallard

Chief Financial & Accounting Officer

Timothy M. Wright

Chief Research & Development Officer

Mary Yaroshevsky-Glanville

Senior Vice President-Human Capital

Christopher Aker

Secretary & Vice President-Legal Affairs

Stelios B. Papadopoulos

Chairman

Kathryn J. Collier

Independent Director

Pascale Witz

Independent Director

Hugh Rosen

Independent Director

David Baltimore

Independent Director

William H. Rastetter

Independent Director

View Profile

Address	10628 Science Center Drive San Diego California 92121 United States
Employees	-
Website	http://www.regulusrx.com
Updated	07/08/2019
Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease.